𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response of osteogenic sarcoma to the combination of etoposide and cyclophosphamide as neoadjuvant chemotherapy

✍ Scribed by Ramy A. Saleh; John Graham-Pole; William Cassano; Frank Abbot; Robert Vander Griend; Nancy Dickson; Paulete Metha; Marj Heare; Amos Kedar; Travis Heare; Samuel Gross

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
458 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neoadjuvant chemotherapy for Ewing's sar
Neoadjuvant chemotherapy for Ewing's sarcoma of bone : No benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase-Results of two sequential studies
✍ Gaetano Bacci; Piero Picci; Stefano Ferrari; Mario Mercuri; Adalberto Brach del πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 121 KB πŸ‘ 1 views

27%) underwent surgery followed by radiation therapy, and 38 (46%) received topedico Rizzoli,

Adenoid cystic carcinoma of the esophagu
Adenoid cystic carcinoma of the esophagus. Complete response to combination chemotherapy
✍ Sigurdur R. Petursson πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 423 KB πŸ‘ 2 views

A 55-year-old man had adenoid cystic carcinoma of the esophagus metastatic to the lungs and right supraclavicular fossa. He was treated with local radiation therapy to the esophagus and supraclavicular fossa, followed by combination chemotherapy with doxorubicin, mitomycin C, and 5-fluorouracil(5-FU

The addition of cisplatin to cyclophosph
The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma : A randomized study of 457 patients
✍ Thierry Urban; Claude Chastang; FranΓ§ois-Xavier Lebas; Jean-Paul Duhamel; Guy Ad πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## BACKGROUND. To assess whether the addition of cisplatin (100 mg/m 2 administered intravenously on Day 1) to CDE (cyclophosphamide [1000 mg/m 2 on Day 1], doxorubicin [45 mg/m 2 on Day 1], and etoposide [150 mg/m 2 on Days 1 and 2] combination is useful in the treatment of patients with small cel

Monitoring the response of patients with
Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography
✍ David A. Mankoff; Lisa K. Dunnwald; Julie R. Gralow; Georgiana K. Ellis; Mariann πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 221 KB πŸ‘ 1 views

## BACKGROUND. Mammographic and physical examination assessments of the response of locally advanced breast carcinoma (LABC) to neoadjuvant therapy have been shown to be inaccurate. The authors studied the feasibility and accuracy of [technetium 99m]-sestamibi (MIBI) for monitoring the response of